Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. 1994

L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
Cell Genesys, Inc., Foster City, California 94404.

We describe a strategy for producing human monoclonal antibodies in mice by introducing large segments of the human heavy and kappa light chain loci contained on yeast artificial chromosomes into the mouse germline. Such mice produce a diverse repertoire of human heavy and light chains, and upon immunization with tetanus toxin have been used to derive antigen-specific, fully human monoclonal antibodies. Breeding such animals with mice engineered by gene targeting to be deficient in mouse immunoglobulin (Ig) production has led to a mouse strain in which high levels of antibodies are produced, mostly comprised of both human heavy and light chains. These strains should provide insight into the adoptive human antibody response and permit the development of fully human monoclonal antibodies with therapeutic potential.

UI MeSH Term Description Entries
D007145 Immunoglobulin kappa-Chains One of the types of light chains of the immunoglobulins with a molecular weight of approximately 22 kDa. Ig kappa Chains,Immunoglobulins, kappa-Chain,kappa-Immunoglobulin Light Chains,Immunoglobulin kappa-Chain,kappa-Chain Immunoglobulins,kappa-Immunoglobulin Light Chain,kappa-Immunoglobulin Subgroup VK-12,kappa-Immunoglobulin Subgroup VK-21,Chains, Ig kappa,Immunoglobulin kappa Chain,Immunoglobulin kappa Chains,Immunoglobulins, kappa Chain,Light Chain, kappa-Immunoglobulin,Light Chains, kappa-Immunoglobulin,kappa Chain Immunoglobulins,kappa Chains, Ig,kappa Immunoglobulin Light Chain,kappa Immunoglobulin Light Chains,kappa Immunoglobulin Subgroup VK 12,kappa Immunoglobulin Subgroup VK 21,kappa-Chain, Immunoglobulin,kappa-Chains, Immunoglobulin
D007148 Immunoglobulin mu-Chains The class of heavy chains found in IMMUNOGLOBULIN M. They have a molecular weight of approximately 72 kDa and they contain about 57 amino acid residues arranged in five domains and have more oligosaccharide branches and a higher carbohydrate content than the heavy chains of IMMUNOGLOBULIN G. Ig mu Chains,Immunoglobulins, mu-Chain,Immunoglobulin mu-Chain,mu Immunoglobulin Heavy Chain,mu Immunoglobulin Heavy Chains,mu-Chain Immunoglobulins,Chains, Ig mu,Immunoglobulin mu Chain,Immunoglobulin mu Chains,Immunoglobulins, mu Chain,mu Chain Immunoglobulins,mu Chains, Ig,mu-Chain, Immunoglobulin,mu-Chains, Immunoglobulin
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D005803 Genes, Immunoglobulin Genes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity). Genes, Ig,Immunoglobulin Genes,Gene, Ig,Gene, Immunoglobulin,Ig Gene,Ig Genes,Immunoglobulin Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
January 2014, Methods in molecular biology (Clifton, N.J.),
L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
January 2019, Methods in molecular biology (Clifton, N.J.),
L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
June 1998, Journal of immunological methods,
L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
August 1998, Hybridoma,
L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
December 1994, AIDS research and human retroviruses,
L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
September 1981, Proceedings of the National Academy of Sciences of the United States of America,
L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
September 2009, The Journal of biological chemistry,
L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
September 1994, Journal of medical primatology,
L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
December 2012, Hybridoma (2005),
L L Green, and M C Hardy, and C E Maynard-Currie, and H Tsuda, and D M Louie, and M J Mendez, and H Abderrahim, and M Noguchi, and D H Smith, and Y Zeng, and N E David, and H Sasai, and D Garza, and D G Brenner, and J F Hales, and R P McGuinness, and D J Capon, and S Klapholz, and A Jakobovits
September 1989, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!